No Detail Found!

Comparative Study of Two Ionotropes Levosimendan and Dobutamine in Critically Ill Patients Suffering from Heart Failure.

Author(s)
Dharmendra Jain Department of Cardiology, Institute of Medical Sciences, Banaras Hindu University Campus, Varanasi, Uttar Pradesh, India
Sandeep Loha Department of Anesthesiology, Institute of Medical Sciences, Banaras Hindu University Campus, Varanasi, Uttar Pradesh, India
Dhirendra Chandrakar Department of Anesthesiology, Institute of Medical Sciences, Banaras Hindu University Campus, Varanasi, Uttar Pradesh, India
Manimoy Debburma Department of Anesthesiology, Institute of Medical Sciences, Banaras Hindu University Campus, Varanasi, Uttar Pradesh, India
Dinesh Kumar Singh Department of Anesthesiology, Institute of Medical Sciences, Banaras Hindu University Campus, Varanasi, Uttar Pradesh, India
Abstract
Objective: Acute heart failure frequently happens in critically ill patients due to myocardial injury, cardiac dysfunction, arrhythmias, and inflammatory mediators. Till now, the outcomes of studies comparing levosimendan with dobutamine for patients requiring inotropic support remain controversial and ambiguous. The present study was aimed to compare the effects of levosimendan and dobutamine in the management of critically ill patients in ICU and establish preference of one over the other drug. Methodology: In this study 100 critically ill patients with clinical diagnosis of heart failure or impending heart failure due to any cause of age between 21 years to 80 years (left ventricular ejection fraction 0.05) in both the groups. Heart rate decreased significantly in both the groups at 24 h and 5th day, although it remained higher in Group-1 patients receiving levosimendan. Systolic blood pressure and Cardiac Index (CI) increased significantly in both the groups but was more in Group-1 patients receiving levosimendan at all times. Cardiac output increased significantly in Group-1 pts whereas in Group-2, after an initial increase for first 48 hrs ultimately decrease in cardiac output was observed on 5th day. 7 Day survival was more (56%) in Group-1 patients as compared to 52% in Group-2 patients. Conclusion: Based upon the results of our study, we conclude that levosimendan shows better results than dobutamine in maintaining hemodynamic stability in critically ill patients. Larger, multi-center studies may have to be done for confirming or discrediting our results.
Publication Details
Page(s) 456-462
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 22, Issue: 4, Year: 2018

Request the full text from PASTIC

0

Citations

0

Downloads

134

Views